ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 171,47
0,70%
Dow Jones
41 853,27
0,65%
DAX
23 288,06
-0,45%
Brent Oil
70,875
1,03%
Bitcoin
84 584,94
2,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) Actualités

RZLT

Rezolute (RZLT)

Rezolute Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DateHeureSourceTitreSymboleSociété
21/02/202501h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
12/02/202522h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
12/02/202522h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
12/02/202522h05GlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
04/02/202514h00GlobeNewswire Inc.Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
31/01/202514h00GlobeNewswire Inc.Rezolute to Participate in the Guggenheim SMID Cap Biotech ConferenceNASDAQ:RZLTRezolute Inc
07/01/202514h00GlobeNewswire Inc.Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
30/12/202422h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RZLTRezolute Inc
05/12/202414h00GlobeNewswire Inc.Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RZLTRezolute Inc
03/12/202414h00GlobeNewswire Inc.FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor HyperinsulinismNASDAQ:RZLTRezolute Inc
15/11/202400h59Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RZLTRezolute Inc
07/11/202422h05GlobeNewswire Inc.Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
05/11/202414h00GlobeNewswire Inc.Rezolute to Participate in Upcoming Investor ConferencesNASDAQ:RZLTRezolute Inc
21/10/202422h43Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RZLTRezolute Inc
21/10/202422h41Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RZLTRezolute Inc
10/10/202422h40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RZLTRezolute Inc
19/09/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RZLTRezolute Inc
19/09/202422h05GlobeNewswire Inc.Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
09/09/202413h30GlobeNewswire Inc.FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 StudyNASDAQ:RZLTRezolute Inc
15/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
10/08/202403h47Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
05/08/202423h00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RZLTRezolute Inc
05/08/202413h30GlobeNewswire Inc.Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor HyperinsulinismNASDAQ:RZLTRezolute Inc
31/07/202414h00GlobeNewswire Inc.Rezolute to Participate in the BTIG Virtual Biotechnology ConferenceNASDAQ:RZLTRezolute Inc
27/06/202414h00GlobeNewswire Inc.Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private PlacementNASDAQ:RZLTRezolute Inc
24/06/202414h00GlobeNewswire Inc.Rezolute Announces Closing of Public Offering with Approximately $60M in Gross ProceedsNASDAQ:RZLTRezolute Inc
14/06/202422h49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RZLTRezolute Inc
14/06/202405h30GlobeNewswire Inc.Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded WarrantsNASDAQ:RZLTRezolute Inc
13/06/202422h01GlobeNewswire Inc.Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:RZLTRezolute Inc
30/05/202414h00GlobeNewswire Inc.Rezolute to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Dernières Valeurs Consultées

COIN
HUSDETH
HUSD
BIT
UC7BE2
Unicredit Bank
BIT
WHIK26
Haiki
USOTC
EEENF
88 Energy (PK)
ASX
XRGNC
XReality
NYSE
HPE
Hewlett Packard Enterprise
NYSE
WMS
Advanced Drainage Systems
BIT
P1T144
BNP Paribas Issuance
AMEX
EWY
iShares MSCI South Korea...
COIN
LINKGBP
ChainLink Token
COIN
SUIGBP
SUI Network
LSE
BMR
BMR Mining
NYSE
ADM
Archer Daniels Midland
DOWI
DJECONNA
DJ Emerging Markets Cons...
AMEX
XLF
Financial Select Sector
USOTC
ATHNY
Athens International Air... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces